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Pesticides are used worldwide to control both
agricultural and household pests. In 2001, the
United States alone used approximately
122 million pounds of insecticides, and 12%
of those compounds were for home and gar-
den use [U.S. Environmental Protection
Agency (EPA) 2001]. One of the most fre-
quently used classes of pesticides is the syn-
thetic pyrethroids (Roberts and Hutson
1999). They represented approximately one-
fourth of the worldwide market for insecti-
cides in 1998 (Casida and Quistad 1998),
and their use has continued to grow.
Pyrethroid pesticides are the synthetic
analogs of the naturally occurring toxin
pyrethrin, which is derived from the ﬂowers of
Chrysanthemum cinerariaefolium. Pyrethroids
exert their toxic action by binding to the volt-
age-dependent sodium channel in nervous tis-
sue and prolonging the open phase (Soderlund
et al. 2002; Vijverberg and van den Bercken
1990). Although these pesticides have been
modiﬁed to be more photostable, more lipo-
philic, and more toxic than pyrethrin, they are
considerably less toxic to mammals than are
other classes of insecticides, such as organo-
chlorines, organophosphates, and carbamates.
Because of their low acute human toxicity,
pyrethroids are widely used to control insects
in and around homes (Freeman et al. 2004)
and day care facilities. Tulve et al. (2006)
detected two permethrin isomers and 13 dif-
ferent pyrethroids, including esfenvalerate
(ESF), in ﬂoor wipe samples taken from 168
day care centers in the United States.
In addition to household exposures, chil-
dren may also consume pyrethroids in their
diet. Permethrin and fenvalerate residues have
been detected in selected baby food [Food
and Drug Administration (FDA) 2005).
Additionally, permethrin, cyfluthrin, cyper-
methrin, and deltamethrin have been
detected in human breast milk in women liv-
ing in an area of South Africa in which
pyrethroids were used for malaria control.
(Bouwman et al. 2006). Pyrethroid metabo-
lites have also been measured in urine samples
taken from children with no known previous
exposure (Heudorf and Angerer 2001).
However, that study found no correlation
between levels of permethrin (the only
pyrethroid found in analyzed household dust
samples) and levels of pyrethroid metabolites
in the urine, leading those researchers to con-
clude that the exposure route was primarily
dietary. However, in a study measuring
pyrethroid metabolites in the urine of children
3–11 years of age, Lu et al. (2006) found that
self-reported residential pyrethroid use was
signiﬁcantly associated with metabolite levels,
whereas changing the diet from conventional
to organic was not. Thus, pyrethroid exposure
in this group of children is likely to have
occurred primarily through the environment.
Only a few published reports of dietary
intake levels of the different pyrethroids are
available. The average daily intake for perme-
thrin for a man weighing 70 kg was estimated
at 3.2 μg/day, which is less than the acceptable
daily intake of 50 μg/kg/day [Centers for
Disease Control and Prevention (CDC)
2005], but no average daily intakes for chil-
dren were listed. However, in a recent study
Bouwman et al. (2006) calculated daily intakes
of permethrin (13.6 μg/kg), cyfluthrin
(73.4 μg/kg), and deltamethrin (13.3 μg/kg)
for infants based on levels measured in breast
milk of women living in three separate regions
of Africa. Although calculated intakes of per-
methrin and cyfluthrin were below the cur-
rently established acceptable daily intake levels,
those of deltamethrin exceeded the acceptable
daily intake by 3.3 μg/kg. 
Although the overall incidence of fatalities
and severe poisonings due to pyrethroids is
lower than that of the organophosphates, sev-
eral in vitro studies have indicated that
pyrethroids may have estrogenic activity, caus-
ing them to be placed on the U.S. EPA’s list
of possible endocrine disruptors (Colborn
et al. 1993; U.S. EPA 1997). Fenvalerate has
been shown to induce proliferation and
increase the expression of the estradiol (E2)-
inducible gene pS2 and the proto-oncogene
Wnt10B in MCF-7 breast cancer cells (Chen
et al. 2002; Go et al. 1999; Kasat et al. 2002).
Lemaire et al. (2006) showed that fenvalerate
was able to increase transcription via estrogen
receptor-α (ER-α) in stably transfected
HELN cells. Other studies have shown con-
ﬂicting data in which fenvalerate had no effect
on pS2 mRNA expression, ER binding, or ER
expression (Kim et al. 2004). Furthermore,
fenvalerate has been shown to inhibit MCF-7
BUS (a variant MCF-7 cell line) proliferation
in the presence of 17β-E2, leading to specula-
tion that it is a possible antiestrogen (Kim
et al. 2004).
Most of the data suggesting the estrogenic
action of the type II pyrethroids have come
primarily from in vitro studies using human
cancer cell lines. When synthetic pyrethroids,
including fenvalerate, were tested by other
screening assays, such as the luciferase reporter
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BACKGROUND: One of the most widely used classes of insecticides is the synthetic pyrethroids.
Although pyrethroids are less acutely toxic to humans than to insects, in vitro studies have sug-
gested that pyrethroids may be estrogenic. 
OBJECTIVES: We assessed pubertal effects by orally administering 0.5, 1.0, and 5.0 mg/kg/day of
the type II pyrethroid esfenvalerate (ESF) to female rats beginning on postnatal day (PND) 22 until
vaginal opening. ESF administration suppresses serum estradiol and delays pubertal onset. 
MATERIALS AND METHODS: To assess possible hypothalamic and/or pituitary effects, animals
received 0.5 or 1.0 mg/kg ESF or corn oil on PNDs 22–29. On PND30, we drew three blood sam-
ples (200 µL) from each rat at 15-min intervals beginning at 1000 hours, and again at 1500 hours.
To test hypothalamic responsiveness, after the third afternoon sample, all animals received an intra-
venous injection of N-methyl-D,L-aspartic acid (NMA; 40 mg/kg), and then we drew two more
samples. We performed a second experiment as above except that animals received luteinizing hor-
mone–releasing hormone (LHRH; 25 ng/rat) to test pituitary responsiveness.
RESULTS: Basal levels of luteinizing hormone (LH) in the afternoon hours were higher in control
animals than in animals treated with 1.0 mg/kg ESF (p < 0.05). Furthermore, NMA- and LHRH-
stimulated LH release was similar in control and ESF-treated animals, indicating that both hypo-
thalamic and pituitary responsiveness, respectively, were unaffected. 
CONCLUSIONS: Although the hypothalamus is able to respond to exogenous stimuli, absence of a
normal afternoon rise in LH would indicate a hypothalamic deﬁcit in ESF-treated animals. 
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http://dx.doi.org/ [Online 13 May 2008]gene assay (Andersen et al. 2002), yeast two-
hybrid assay, and competitive ligand-binding
assay using ﬂuoromone ES1, the results were
negative for estrogenic activity (Saito et al.
2000). Additionally, in vivo screening tests
[Organisation for Economic Co-operation
and Development (OECD) 1997] that
assessed the estrogenic and androgenic effects
of the pyrethroids fenvalerate, ESF, and per-
methrin found no significant changes in the
accessory sex glands or uterine weights of cas-
trated adult male and female rats, respectively,
after treatment with the pesticides (Kunimatsu
et al. 2002), thus calling into question the
conclusions of estrogenic activity drawn from
the in vitro data.
However, none of the in vivo studies has
evaluated the neuroendocrine effects of oral
exposure to low doses of type II pyrethroids in
immature animals. Because children and ado-
lescents are exposed to pyrethroids and because
of the conﬂicting data regarding the possible
endocrine-disrupting capability of these pesti-
cides, we wanted to assess the effects of short-
term oral administration of a low dose of a
type II pyrethroid on the onset of female
puberty and on the levels of pubertal hormones
in vivo.
We chose to evaluate the pyrethroid pesti-
cide ESF [benzeneacetic acid, 4-chloro-α-(1-
methylethyl)-, cyano(3-phenoxyphenyl)methyl
ester] because it is used both in the home
(Ortho Bug-B-Gon; Scotts Miracle-Gro
Company, Marysville, OH) and on a wide
variety of crops, including fruits, vegetables,
and nuts [Extension Toxicology Network
(EXTOXNET) 1996].
Material and Methods
Animals. For these experiments, we used
immature female Sprague-Dawley rats raised
in our colony at the Texas A&M University
Department of Comparative Medicine. The
animals were housed under controlled condi-
tions of photoperiod (lights on at 0600 hours;
lights off at 1800 hours) and temperature
(23°C), with ad libitum access to food and
water. All procedures used were approved
by the University Animal Care and Use
Committee and in accordance with the
National Institutes of Health Guide for the
Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources 1996).
Animals were treated humanely and with
regard for alleviation of suffering. Rats were
bred and allowed to deliver their pups nor-
mally. On postnatal day (PND) 2, pups were
culled from individual litters, if necessary,
so that the litter size for each dam was
10–12 pups total, with at least 5–6 females
per litter. We used female pups from 50 sepa-
rate litters for the experiments. For all experi-
ments, we randomly assigned littermates to
treatment groups.
Pesticide. We purchased ESF (Asana
98%, lot 306-118A, expiration date July
2009; and lot 328-113B, expiration date
September 2010) from Chem Service, Inc.
(West Chester, PA) and dissolved it in corn
oil (Sigma Chemical Co., St. Louis, MO) for
the dosing studies. We mixed dosing solution
every other day and stored it at room temper-
ature protected from light. Control animals
received an equal volume of corn oil.
Effect of ESF exposure on puberty-related
hormones and the onset of puberty. For the ﬁrst
experiment, we administered 0.5, 1.0, or
5.0 mg/kg/day ESF by gastric gavage to female
pups beginning on PND22 and continuing
until vaginal opening (VO) occurred. We used
a random-block experimental design. We ran-
domly assigned pups from multiple litters to
either a control or treatment group, so that
each ESF treatment group had its own control
group. Dosing occurred in the morning, and
dosing volume was 10.0 mL/kg (0.1 mL/
10.0 g) body weight. Once VO occurred, we
performed vaginal lavage daily and observed
cytology until ﬁrst diestrus (D1), which indi-
cates sexual maturity (Nyberg et al. 1993). In
the second experiment, we randomly assigned
PND22 female pups from multiple litters to 0,
0.5, 1.0, or 5.0 mg/kg ESF, gavaged them as
previously described until PND29. All animals
were killed by decapitation between 0900 and
1100 hours in a random order and were con-
firmed to be prepubertal by well-established
criteria (Dees and Skelley 1990). Briefly, all
animals had small uteri, no intraluminal ﬂuid,
and closed vaginas. Trunk blood was collected,
centrifuged it at 4°C, and stored at –80°C
until assayed for luteinizing hormone (LH),
follicle-stimulating hormone (FSH), and E2.
Effect of ESF on morning and afternoon
basal levels of LH and hypothalamic responsive-
ness to N-methyl-D,L-aspartic acid (NMA).
Animals were dosed with 0, 0.5, or 1.0 mg/kg
ESF from PND22 to PND29. The 29-day-old
female rats were then anesthetized with 2.5%
tribromoethanol (Aldrich, Milwaukee, WI) and
Silastic cannulas were inserted into the right
external jugular vein of each rat (Harms and
Ojeda 1974). The next day, an extension of
tubing was attached to each cannula and
ﬂushed with heparinized saline (100 IU/mL).
After a 1-hr acclimation period, three basal
blood samples (200 μL) were drawn at 15-min
intervals from each freely moving animal,
beginning at 1000 hours. All animals received
an equal volume of heparinized saline to replace
blood volume. The animals were left undis-
turbed until 1500 hours, at which time three
more samples were taken at 15-min intervals.
After the third afternoon sample, we conducted
a hypothalamic response test by administering a
single intravenous injection of NMA (Sigma) at
a dose of 40 mg/kg (Gore et al. 1996; Nyberg
et al. 1993). NMA is known to induce release
of luteinizing hormone–releasing hormone
(LHRH) in rats (Bourguignon et al. 1990;
Nyberg et al. 1993; Smyth and Wilkinson
1994; Urbanski and Ojeda 1987) and primates
(Claypool et al. 2000; Dissen et al. 2004; Gay
and Plant 1987) after binding to the hypothala-
mic NMDA receptors. We collected two addi-
tional blood samples at 15-min intervals after
the NMA injection. After the experiment, ani-
mals were euthanized with an overdose of tri-
bromoethanol. Animals were conﬁrmed to be
anestrus, and serum was stored as described
above until assayed for LH.
LHRH stimulation in pesticide-treated
juvenile females. We treated a separate group
of animals as described for the NMA stimula-
tion experiment except after the third after-
noon sample, we intravenously administered
Pine et al.
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Figure 1. Effect of short-term oral administration of ESF at 5 mg/kg (A), 1 mg/kg (B), and 0.5 mg/kg (C) on
the age at VO. VO was delayed by 2 days in animals treated with 5.0 mg/kg ESF (A) and by 1 day in animals
treated with 1.0 mg/kg ESF (B). Values represent mean ± SE; the number within each bar indicates the
number of animals.
*p < 0.05, and **p < 0.01 compared with control. 
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Figure 2. Effect of short-term oral administration of
ESF on serum E2 in female rats on PND29. The
1.0-mg/kg dose caused a 1.3-fold decrease in serum
E2, whereas the 5.0 mg/kg dose caused a 2-fold
decrease. Values represent mean ± SE; the number
within each bar indicates the number of animals.
*p < 0.05, and **p < 0.01 compared with control. 
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26 19 19 20LHRH (25 ng). Again, two samples were col-
lected at 15-min intervals after LHRH treat-
ment; samples were stored as described above.
Hormone analysis. We measured rat LH
and FSH using radioimmunoassay (RIA) pro-
cedures as previously described (Hiney et al.
1996). Rat LH antiserum (NIDDK-anti-rLH-
S-II), antigen (NIDDK-rLH-I-9), and refer-
ence preparation (NIDDK-rLH-RP-3) and
FSH antiserum (NIDDK-rFSH-I-9) and refer-
ence preparation (NIDDK-rFSH-RP-2) were
purchased from the National Institutes of
Health Pituitary Hormones and Antisera
Center (Harbor-UCLA Medical Center,
Torrance, CA). The LH assay had a sensitivity
of 0.07 ng/mL, and the FSH assay had a sensi-
tivity of 0.4 ng/mL. We measured serum E2
using an RIA kit purchased from Diagnostic
Products Corp. (Los Angeles, CA) as previously
described (Hiney et al. 1996). The E2 assay sen-
sitivity was 8.0 pg/mL. All assays had inter- and
intra-assay coefﬁcients of variation of < 10%.
Statistical analysis. Values are expressed as
the mean ± SE. We analyzed differences
between treatment groups in timing of
puberty using the Student’s paired t-test; hor-
mone levels (morning FSH, LH, and E2) were
analyzed by analysis of variance (ANOVA)
followed by post hoc testing using Student-
Newman-Keuls multiple-range test. We ana-
lyzed differences in LH serum levels among
treatment groups comparing morning, after-
noon, and poststimulation values by the
Kruskal-Wallis test (nonparamteric ANOVA)
followed by Dunn’s multiple comparisons
test. We considered probability values of
p < 0.05 to be statistically signiﬁcant. We used
INSTAT and PRISM software, version 3.0,
for personal computer (GraphPad, San Diego,
CA) to calculate and graph results. 
Results
Effect of ESF exposure on puberty-related hor-
mones and the onset of puberty. Short-term
exposure to ESF during juvenile development
did not alter mean (± SE) daily weight gain at
any dose administered. Controls gained 4.2 ±
0.11 g, whereas animals receiving 5.0, 1.0, and
0.5 mg/kg gained 4.07 ± 0.15, 4.11 ± 0.15,
and 4.25 ± 0.22 g, respectively. However, the
5.0 mg/kg and 1.0 mg/kg doses of the pesti-
cide delayed (p < 0.01 and p < 0.05, respec-
tively) the age at VO compared with corn oil
controls (Figure 1). ESF delayed the onset of
puberty by 2 days in animals dosed with
5.0 mg/kg and by 1 day in females dosed with
the 1.0 mg/kg compared with control animals.
We performed cytologic evaluations on
each rat on their respective day of VO and
determined the stage of the estrous cycle. The
interval from VO to D1 was the same for pes-
ticide-treated and control animals in which
the smear on the day of VO was either
proestrus or estrus (1.25 days).
We then compared serum levels of the
puberty-related hormones LH, FSH, and E2
from PND29 pesticide-treated and control
animals. Animals exposed to the two highest
doses of ESF (1.0 and 5.0 mg/kg) exhibited a
1.3- and 2-fold decrease in serum E2, respec-
tively, compared with controls (Figure 2).
Interestingly, the morning serum levels of both
LH and FSH were unchanged at any dose of
ESF (Figure 3).
Effect of ESF on morning-to-afternoon
basal levels of LH and hypothalamic respon-
siveness to NMA. Because morning LH levels
were unaltered in pesticide-treated animals, we
assessed whether ESF affected the morning-to-
afternoon pattern of LH secretion. During
peripubertal development, the release of LH
becomes more prominent in the afternoon,
which is a centrally mediated event (Ojeda
et al. 1986). To assess whether ESF affects this
pattern of LH secretion, we dosed animals
from PND22 with either the pesticide (0.5 and
1.0 mg/kg) or corn oil and took morning and
afternoon blood samples on PND30. Control
animals exhibited a 2-fold rise in basal after-
noon LH levels compared with the morning
levels (p < 0.01). The mean afternoon LH lev-
els in control animals were higher (p < 0.05)
than those of animals treated with 1.0 mg/kg
ESF (Figure 4).
To assess hypothalamic responsiveness,
animals were injected with NMA after the
third afternoon blood sample to induce LH
release. NMA stimulated marked increases in
LH secretion compared with their respective
afternoon levels in all three groups of animals
(p < 0.05), but we noted no differences
between either ESF treatment group com-
pared with controls. These data demonstrate
that hypothalamic responsiveness to NMA
stimulation was not altered by the pesticide
(Figure 4).
We conducted a ﬁnal experiment to assess
pituitary responsiveness after ESF exposure. We
dosed animals with ESF and collected serial
blood samples as described above, except that
instead of NMA administration, we challenged
these animals with LHRH (25 ng) (Dees et al.
1985). LHRH markedly (p < 0.001) stimulated
LH release over afternoon basal levels in control
and both ESF treatment groups, demonstrating
that pituitary responsiveness was not affected by
the pesticide (data not shown).
Discussion
This is the first study to show an inhibitory
action of a type II pyrethroid pesticide, ESF, on
the hypothalamic control of prepubertal
gonadotropin secretion. This study is also the
ﬁrst to show that short-term administration of
ESF to juvenile animals signiﬁcantly delays the
onset of female puberty. The dose of 1.0 mg/kg
used for our short-term puberty studies was
two times lower than the stated no observable
effect level (NOEL) of 2.0 mg/kg/day used for
the dietary developmental study in rats (U.S.
EPA 1998).
We found only one in vivo study that eval-
uated puberty in female animals exposed to a
type II pyrethroid. Moniz et al. (2005) dosed
pregnant animals with a commercial-grade
formulation (Bernardi MM, personal commu-
nication) of an unknown purity of fenvalerate.
Moniz et al. (2005) found age at VO to be
delayed in exposed offspring. However, com-
mercial-grade formulations typically contain
other compounds, such as solvents and petro-
leum distillates (Meister 1997). No conclu-
sions can be made as to whether the effects
Esfenvalerate delays puberty
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Figure 3. Effect of short-term oral administration of ESF on morning serum LH and FSH levels. Values rep-
resent the mean ± SE; and the number within each bar indicates the number of animals. 
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Figure 4. Effect of short-term oral administration of
ESF on morning, afternoon, and NMA-stimulated
LH release in vivo. Values for morning and after-
noon represent the mean ± SE of three samples for
each time point from each animal; post-NMA LH
levels represent the peak value (number of ani-
mals: controls, n = 12; 0.5 mg/kg NMA, n = 14;
1.0 mg/kg NMA, n = 16).
*p < 0.05 compared with control. **p < 0.05 compared with
afternoon values. 
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mulation, so we cannot directly compare their
results with ours. 
In the present study, we dosed immature
animals 1 day postweaning until just before
the onset of puberty, at which time we meas-
ured morning serum levels of LH, FSH, and
E2. Females dosed with 5.0 and 1.0 mg/kg
ESF had signiﬁcantly suppressed E2 levels.
Interestingly, in our study, ESF did not
affect the morning basal secretion of FSH or
LH. If ESF were acting only at the ovarian
level to suppress serum E2 levels, a compen-
satory increase in LH would be expected
because of the removal of the negative feed-
back effect at the hypothalamus. However,
the morning LH levels in the pesticide-treated
animals were the same as those in controls.
This atypical response to the low E2 suggested
a hypothalamic deﬁcit.
However, our results for afternoon LH lev-
els showed an inhibition in the afternoon hor-
monal rise in animals treated with even the
lowest dose (0.5 mg/kg) of pesticide. The
physiologic pattern of both LH and FSH secre-
tion is periodic and intermittent, although
more so for LH. Before the onset of puberty,
the amplitude of LH release is low; however,
once puberty begins, the release of LH
becomes more prominent in the afternoon.
Both rats and humans exhibit a similar release
pattern (Delemarre-Van De Waal et al. 1991;
Urbanski and Ojeda 1987), which is centrally
driven (Knobil 1980).
Delayed puberty most commonly occurs
because of decreased E2 resulting from either
hypothalamic and/or pituitary dysfunction or
from a direct effect on the ovary. Many toxi-
cants can perturb multiple systems, and ESF
may also be interfering with ovarian steroid
hormone biosynthesis as well. However, if ESF
acted solely on the ovary to suppress E2 synthe-
sis or release, the expected response would be a
compensatory increase in LH levels because of
the feedback mechanism from the ovary to the
hypothalamus and pituitary. Morning LH lev-
els in the pesticide-treated animals were the
same as those in control animals, indicating an
abnormal feedback response.
When we measured LH in serial morning
and afternoon blood samples, the afternoon
rise in LH was suppressed in females dosed at
even the lowest ESF concentration. Based on
the findings of low serum E2 and low after-
noon LH, we expected the ESF-treated ani-
mals to release less LH than controls after
NMA stimulation. However, the ESF-treated
animals responded to NMA stimulation as
well as the controls.
The toxic effects of pyrethroids are caused
by the prolongation of the open state of volt-
age-dependent sodium channels, resulting in
repetitive ﬁring of the neurons. If the delay in
puberty was due to the action of the pesticide
on the sodium channels of the LHRH neurons,
the expected result would be an initial increase
in LH due to the rapid release of LHRH, fol-
lowed by a decrease in LH levels after the
releasable pool of LHRH was exhausted.
One possible site of pyrethroid action that
could potentially cause the delay in puberty is
the NMDA receptor; activation of the NMDA
receptor has been suggested as a mediator of
pyrethroid neurotoxicity (Chugh et al. 1992).
Furthermore, Wu and Liu (2003) found that
both c-fos and c-jun were expressed in adult
male rats exposed to deltamethrin. Blocking
the NMDA receptor with the antagonist MK-
801 eliminated c-fos and c-jun expression, sug-
gesting that the pesticide can act through this
excitatory amino acid (EAA) pathway. A possi-
ble explanation of our data is that ESF may be
interfering with hypothalamic storage, release,
and/or transport of the EAAs.
Any or all of the EAAs, such as glutamate
or aspartate, may not be present in high enough
levels to fully activate the NMDA receptor.
Thus, when we administered the NMDA
receptor agonist, more unoccupied receptor
sites were available for binding and subsequent
stimulation of LHRH release. Other neuro-
transmitters, such as norepinephrine, may also
be adversely affected by the pesticide.
Although the exact mechanism of action is
unknown at this time, we observed the effects
at dosage levels below the NOEL established
through chronic dietary exposure studies in
rats. The U.S. EPA (1998) stated that “There
is no evidence of additional sensitivity to
young rats or rabbits following pre- or post-
natal exposure to esfenvalerate.” The present
study shows that immature female rats exposed
to 1.0 mg/kg/day are sensitive to this pesticide,
as evidenced by their delay in the onset of
puberty. Delayed pubertal onset in humans has
been associated with low bone mass density
(Ho and Kung 2005), and estrogen is neces-
sary for bone mineral acquisition in both girls
and boys (Yilmaz et al. 2005). Importantly, a
lowered endogenous estrogen level in females is
one factor associated with bone fragility
(Hoffman and Bradshaw 2003).
This could potentially affect current
established exposure levels for humans,
because the reference dose for ESF of
0.02 mg/kg/day is based directly on the
rodent NOEL of 2.0 mg/kg/day. Obviously,
more basic research is needed in this area;
because of the worldwide use of this class of
pesticide, further studies are warranted.
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